Biomarin Pharmaceutical Cash Flow Statement (2009-2026) | BMRN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	12.94M	-36.49M	-57.90M	120.80M	27.66M	-6.65M	-0.25M	50.85M	56.04M	40.38M	20.38M	88.66M	107.17M	106.08M	124.94M	185.69M	240.53M	-30.74M	-46.57M	105.53M
Depreciation and Depletion (Quarter)	11.80M	11.40M	10.40M	11.70M	9.50M	8.70M	8.70M	10.30M	9.40M	9.90M	10.70M	12.60M	11.50M	10.90M	11.60M	14.10M	10.60M	10.60M	13.20M	8.80M
Share-based Compensation (Quarter)	54.84M	49.03M	43.89M	47.83M	47.08M	54.66M	46.73M	53.70M	50.16M	48.39M	54.85M	58.25M	47.91M	43.49M	51.92M	37.70M	47.53M	49.27M	46.91M	43.46M
Deferred Taxes (Quarter)	-2.13M	-13.22M	-3.59M	4.80M	-1.34M	-4.20M	-51.34M	-6.36M	1.25M	-15.03M	-24.84M	0.28M	1.25M	12.17M	42.39M	28.43M	33.34M	-13.65M	0.61M	9.22M
Gains from Equity Investments (Quarter)
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	37.86M	-37.41M	-1.32M	-1.44M	2.78M	-13.48M	12.14M	1.01M	0.62M	-1.64M		-0.13M	23.01M	-21.63M	-21.39M	1.27M	49.82M	-51.09M	2.71M	28.18M
Asset Writedowns and Impairment (Quarter)								12.65M			14.00M		9.67M	6.78M	-19.89M	2.97M			122.05M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	82.78M	97.06M	11.18M	-45.43M	56.23M	158.32M	6.79M	-73.93M	70.06M	135.65M	27.48M	46.97M	118.76M	221.48M	185.63M	174.39M	185.27M	368.69M	99.64M	220.65M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-1.21M	-1.40M	-1.88M	-1.65M	-1.42M	-0.67M	0.70M	1.97M	2.56M	2.25M	2.45M	2.50M	2.18M	1.94M	1.73M	1.36M	1.35M	0.98M	1.11M	0.46M
Amortization of Deferred Charges (Quarter)	0.15M	0.15M	1.03M	1.03M	0.15M	0.15M	1.03M	1.03M	0.15M	0.15M	0.99M	0.99M	0.15M	0.07M	0.66M	0.66M	0.03M	0.03M	0.65M	0.28M
Depreciation & Amortization (CF) (Quarter)	27.23M	26.84M	25.99M	27.34M	25.27M	24.80M	24.55M	26.42M	25.42M	25.68M	26.86M	27.35M	26.46M	19.01M	23.61M	22.07M	18.56M	18.49M	20.44M	16.41M
Change in Working Capital
Change in Receivables (Quarter)	22.87M	-48.09M	-0.06M	54.81M	37.75M	-38.81M	28.28M	138.80M	7.04M	-13.89M	58.49M	3.39M	52.70M	74.38M	-72.55M	57.59M	98.53M	-48.75M	120.68M	7.16M
Change in Inventory (Quarter)	-12.80M	25.50M	15.94M	-1.12M	2.56M	25.99M	40.84M	14.10M	42.38M	41.47M	59.11M	16.82M	30.59M	-18.15M	34.27M	24.34M	48.13M	26.33M	18.13M	-44.49M
Change in Accured Expenses (Quarter)	72.89M	-0.32M	15.42M	1.71M	-78.06M	73.09M	62.27M	-31.69M	6.59M	81.43M	-32.75M	-59.01M	4.75M	122.28M	-53.26M	-2.65M	8.19M	113.94M	-53.34M	3.10M
Other Working Capital Changes (Quarter)	8.45M	7.30M	-2.73M	8.01M	3.99M	-3.44M	-16.38M	36.00M	17.43M	5.96M	-9.05M	17.35M	-18.97M	21.55M	-16.16M	6.33M	8.77M	17.03M	-41.02M	11.55M
Investing Activities
Capital Expenditures (Quarter)	22.60M	18.73M	28.74M	28.82M	27.15M	29.30M	35.69M	24.46M	21.58M	21.73M	28.92M	26.10M	21.33M	18.46M	19.53M	16.77M	17.10M	28.45M	40.72M	20.92M
Sales of Property, Plant and Equipment (Quarter)				110.00M			-6.67M					10.00M
Change in Intangibles (Quarter)	3.65M	1.63M	15.62M	1.86M	0.88M	7.17M	0.67M	0.31M	1.15M	1.68M	7.78M	8.00M	0.51M	2.71M	0.77M		0.27M	5.30M	2.37M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	154.30M	153.17M	188.94M	155.82M	155.78M	165.65M	142.75M	215.12M	275.94M	260.61M	113.19M	131.53M	186.12M	160.79M	154.58M	77.80M	117.93M	98.81M	43.25M	767.28M
Cash from Investing Activities (Quarter)	-120.26M	-119.85M	-55.42M	87.78M	-29.70M	-23.40M	-54.71M	-30.01M	29.53M	-45.80M	-64.96M	-14.24M	90.48M	-16.16M	76.40M	-28.24M	-12.59M	-330.96M	-42.45M	725.53M
Financing Activities
Other financing activities (Quarter)	0.70M	-0.02M	0.00M				-2.60M				-9.52M	-0.04M	-0.02M	-3.02M	-0.09M				-0.89M	8.65M
Cash from Financing Activities (Quarter)	10.95M	-1.03M	14.40M	-25.28M	-11.78M	7.54M	10.87M	-40.74M	11.96M	-0.79M	10.84M	-42.79M	12.61M	-499.12M	2.86M	-38.78M	-4.60M	-2.17M	3.16M	813.17M
Additional items
Exchange Rate Effect (Quarter)	0.74M	-0.57M	-0.02M	1.09M	-0.39M	-0.75M	0.07M	0.23M	2.75M	1.97M	-3.65M	1.93M	3.30M	-2.90M	2.50M	-1.42M	-3.06M	0.74M	1.22M	1.41M
Change in Cash (Quarter)	-25.78M	-24.39M	-29.87M	18.16M	14.36M	141.71M	-36.98M	-144.46M	114.31M	91.03M	-30.29M	-8.13M	225.15M	-296.70M	267.39M	105.96M	165.01M	36.29M	61.57M	1,760.76M
Free Cash Flow (Quarter)	60.19M	78.33M	-17.56M	-74.25M	29.07M	129.02M	-28.90M	-98.39M	48.48M	113.91M	-1.43M	20.87M	97.44M	203.02M	166.10M	157.63M	168.17M	340.24M	58.92M	199.73M
Net Cash Flow (Quarter)	-26.52M	-23.82M	-29.84M	17.07M	14.75M	142.46M	-37.05M	-144.69M	111.56M	89.06M	-26.64M	-10.06M	221.85M	-293.80M	264.89M	107.38M	168.08M	35.55M	60.35M	1,759.35M

Research Tools

Biomarin Pharmaceutical Cash Flow Statement (2009-2026) | BMRN

Create an account

Sign In

Reset Password